A ‘breadth of protection’: Novavax’s newly approved COVID vaccine arms the U.S. with a new weapon against Omicron BA.5 subvariant - Fortune

Novavax says its vaccine prompted 'broad immune responses' against all COVID variants, including BA.5, in clinical data.

Skip to Content

full article...